UPDATED: 05.08.08 PM -- The Chairman's Opening Statement is now up.
I will have a live, streaming video feed in an embedded window, here, of the entire hearing -- the feed will go "live" at about 9:50 AM EDT, on Thursday May 8, 2008. Be sure to check back, as I've ll updated this post with a full list of witnesses, very likely including a senior Schering-Plough-Merck Joint Venture executive -- but Deepak Khanna (VP & GM MSP J/V) will likely not appear before the luncheon break, as he is on Panel III, the last panel. Do check in on us during the morning -- I'll live-blog any really important updates, in the yellow-box, at lower left. . . .
Feel free to leave your thoughts, questions, etc. as well, there.
Direct-to-Consumer Advertising:
Marketing, Education, or Deception?
[NOTE: You'll need to have
Windows Media Player installed.]
Subcommittee on Oversight and
Investigations Hearing
10:00 AM EDT, Room 2123
Rayburn House Office Building
WITNESS LIST:
Panel IRuth S. Day, Ph.D. -- Statement (PDF File)
Director, Medical Cognition Laboratory
Duke University
Panel IIMollyann Brodie, Ph.D. -- Statement (PDF File)
Vice President
Director Public Opinion and Media Research
Kaiser Family Foundation
Marcia G. Crosse, Ph.D. -- Statement (PDF File)
Director Health Care
US Government Accountability Office
Nacy H. Nielsen, M.D., Ph.D. -- Statement (PDF File)
President-Elect
American Medical Association
Panel IIIMr. Deepak Khanna -- Statement (PDF File)
Senior Vice President and General Manager,
Merck/Schering-Plough Pharmaceuticals
Mr. James Sage -- Statement (PDF File)
Senior Director/Team Leader, Lipitor
Pfizer, Inc.
Ms. Kim Taylor -- Statement (PDF File)
President,
Ortho Biotech, Inc.,
(A Wholly-owned Subsidiary of)
Johnson & Johnson
By Order of the Chairman:
[At Least One Effect of DTC Advertising?]
1 comment:
At the Committee Hearing on DTC Advertising this Thursday, all the pharmaceutical industry "friendly" questions -- and outright defenses -- of Pharma's DTC advertising -- came from one or more of these House Republicans:
Rep. Whitfield (R-KY), who gets significant PAC money (per FEC.gov website) from Abbott, Smith Kline Beecham, Merck, Novartis and Lilly, among others.
Rep. Burgess (R-TX), who gets significant PAC money (per FEC.gov website) from Amgen, HCA, Johnson & Johnson, Merck, Medimmune, Novartis, Roche and Schering-Plough, among others.
Rep. Ferguson (R-NJ), who gets significant PAC money (per FEC.gov website) from Bristol Meyer Squibb, Becton Dickinson, CR Bard, Merck and Johnson & Johnson, among others.
Rep. Barton (R-TX), who gets significant PAC money (per FEC.gov website) from Bayer, among others.
Rep. Shimkus (R-IL), who gets significant PAC money (per FEC.gov website) from Merck, Pfizer, Smith-Kline-Beecham, Novartis and others.
Gee -- that's interesting, no?
Post a Comment